These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3085299)

  • 41. Transfer of sensitised Lyt 2+ cells triggers acute rejection of pancreatic islet allografts.
    Prowse SJ; Warren HS; Agostino M; Lafferty KJ
    Aust J Exp Biol Med Sci; 1983 Apr; 61 (Pt 2)():181-5. PubMed ID: 6411053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations of the T-cell population in BXSB mice: early imbalance of 9F3-defined Lyt-2+ subsets occurs in the males with rapid onset lupic syndrome.
    Dumont FJ; Habbersett RC
    Cell Immunol; 1986 Aug; 101(1):39-50. PubMed ID: 3488821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.
    Kruisbeek AM; Mond JJ; Fowlkes BJ; Carmen JA; Bridges S; Longo DL
    J Exp Med; 1985 May; 161(5):1029-47. PubMed ID: 3921649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stimulation of murine T cells via the Ly-6C antigen: lack of proliferative response in aberrant T cells from lpr/lpr and gld/gld mice despite high Ly-6C antigen expression.
    Dumont FJ
    J Immunol; 1987 Jun; 138(12):4106-13. PubMed ID: 2438334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subpopulations of mouse Lyt-2+ T cells defined by the expression of an Ly-6-linked antigen, B4B2.
    Fichtner AT; Anderson S; Mage MG; Sharrow SO; Thomas CA; Kung JT
    J Immunol; 1987 Apr; 138(7):2024-33. PubMed ID: 2435788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of neural allograft rejection in the mouse following in vivo depletion of L3T4+ but not LYT-2+ T-lymphocytes.
    Nicholas MK; Chenelle AG; Brown MM; Stefansson K; Arnason BG
    Prog Brain Res; 1990; 82():161-7. PubMed ID: 2290933
    [No Abstract]   [Full Text] [Related]  

  • 48. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
    Blazar BR; Hirsch R; Gress RE; Carroll SF; Vallera DA
    J Immunol; 1991 Sep; 147(5):1492-503. PubMed ID: 1831826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL; Wheelahan J; McKenzie IF; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract]   [Full Text] [Related]  

  • 50. Cells mediating graft rejection in the mouse. III. Ly-1+ precursor T cells generate skin graft rejection.
    Loveland BE; McKenzie IF
    Transplantation; 1982 Apr; 33(4):407-10. PubMed ID: 7041367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of L3T4 and Lyt-2 monoclonal antibodies on islet xenograft (rat to mouse) rejection.
    Kawai M; Gotoh M; Monden M; Yamamoto H; Ichikawa T; Valdivia LA; Mori T; Uenaka A; Nakayama E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2709-10. PubMed ID: 2495677
    [No Abstract]   [Full Text] [Related]  

  • 52. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies.
    Cobbold SP; Martin G; Waldmann H
    Eur J Immunol; 1990 Dec; 20(12):2747-55. PubMed ID: 1980112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of helper function with anti-Lyt-2 or anti-L3T4 monoclonal antibodies depending on stimulating antigens.
    Guimezanes A; Schmitt-Verhulst AM
    Eur J Immunol; 1985 Dec; 15(12):1187-91. PubMed ID: 2935405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
    Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
    J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency analysis of class I MHC-reactive Lyt-2+ and class II MHC-reactive L3T4+ IL 2-secreting T lymphocytes.
    Heeg K; Steeg C; Schmitt J; Wagner H
    J Immunol; 1987 Jun; 138(12):4121-7. PubMed ID: 3108383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effector cells in allelic H-2 class I-incompatible skin graft rejection.
    Ichikawa T; Nakayama E; Uenaka A; Monden M; Mori T
    J Exp Med; 1987 Oct; 166(4):982-90. PubMed ID: 3309129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of effector cells from T cell subsets. III. Synergy between Lyt-1 and Lyt-123/23 lymphocytes in the generation of H-2-restricted and alloreactive cytotoxic T cell.
    Simon MM; Edwards AJ; Hämmerling U; McKenzie IF; Eichmann K; Simpson E
    Eur J Immunol; 1981 Mar; 11(3):246-50. PubMed ID: 6972309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
    Dialynas DP; Quan ZS; Wall KA; Pierres A; Quintáns J; Loken MR; Pierres M; Fitch FW
    J Immunol; 1983 Nov; 131(5):2445-51. PubMed ID: 6415170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
    J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.